Work

Primary anti-VEGF-refractory metastatic renal cell carcinoma (mRCC): Clinical characteristics, risk factors, and subsequent therapy.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.7_suppl.305

Authors: D. Y. Heng, M. J. MacKenzie, U. N. Vaishampayan, J. J. Knox, G. A. Bjarnason, M. Tan, L. Wood, F. Donskov, B. I. Rini, T. K. Choueiri

Institutions: Cleveland Clinic, Sunnybrook Health Science Centre, University of Calgary, Wayne State University, Queen Elizabeth II Health Sciences Centre, Aarhus University Hospital, Princess Margaret Cancer Centre, The Barbara Ann Karmanos Cancer Institute, National Cancer Centre Singapore, Odette Cancer Centre

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560320562

Cites:

Cited by: 23

Related to: 10